Brandywine Global Investment Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-94,422
Closed -$2.14M 711
2023
Q4
$2.14M Sell
94,422
-3,378
-3% -$73.2K 0.02% 555
2023
Q3
$2.42M Sell
97,800
-1,542
-2% -$38.8K 0.02% 523
2023
Q2
$2.79M Buy
99,342
+209
+0.2% +$5.19K 0.02% 495
2023
Q1
$2.21M Buy
99,133
+10,134
+11% +$265K 0.02% 532
2022
Q4
$2.36M Sell
88,999
-2,814
-3% -$91.8K 0.02% 528
2022
Q3
$2.6M Sell
91,813
-3,552
-4% -$91.3K 0.02% 483
2022
Q2
$1.99M Buy
+95,365
New +$1.79M 0.02% 537
2014
Q3
Sell
-19,540
Closed -$128K 963
2014
Q2
$128K Sell
19,540
-10,500
-35% -$69.4K ﹤0.01% 767
2014
Q1
$243K Sell
30,040
-560
-2% -$5.51K ﹤0.01% 708
2013
Q4
$306K Sell
30,600
-10,400
-25% -$72.1K ﹤0.01% 686
2013
Q3
$248K Buy
41,000
+4,800
+13% +$27.5K ﹤0.01% 742
2013
Q2
$187K Buy
+36,200
New +$186K ﹤0.01% 774

Other funds holding CCRN

Brandywine Global Investment Management's CCRN Position: Q1 2024 in Review

Brandywine Global Investment Management sold out of Cross Country Healthcare (CCRN) in Q1 2024, closing a stake of 94,422 shares — an estimated $2.14M sold.

Brandywine Global Investment Management first reported a position in CCRN in Q2 2013 and held it in 12 quarters. The position peaked at $2.79M in Q2 2023. 175 funds tracked by Wall St. Rank hold CCRN as of Q1 2024.

  • Brandywine Global Investment Management reported no remaining Cross Country Healthcare position as of Q1 2024 after selling out during the quarter.
  • Brandywine Global Investment Management sold 94,422 Cross Country Healthcare shares in Q1 2024, an estimated $2.14M.
  • Brandywine Global Investment Management first reported a position in Cross Country Healthcare in Q2 2013 and held it in 12 quarters.
  • Brandywine Global Investment Management's Cross Country Healthcare position peaked at $2.79M in Q2 2023.
  • 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2024.

Based on Brandywine Global Investment Management's 13F filing for Q1 2024, filed 13 May 2024.